MedPath
HSA Approval

REGULAIR CHEWABLE TABLET 5mg

SIN14977P

REGULAIR CHEWABLE TABLET 5mg

REGULAIR CHEWABLE TABLET 5mg

April 5, 2016

PAN-MALAYAN PHARMACEUTICALS PTE LTD

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPAN-MALAYAN PHARMACEUTICALS PTE LTD
Licence HolderPAN-MALAYAN PHARMACEUTICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, CHEWABLE

ORAL

Medical Information

R03DC03

montelukast

Manufacturer Information

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited (Dehradun)

Active Ingredients

Montelukast sodium 5.20mg eqv Montelukast

5mg

Montelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

REGULAIR CHEWABLE TABLET 5mg - HSA Approval | MedPath